Interferon type I signaling pathways (WP585)

The type I IFNs (IFNα family, IFNβ, IFNω, IFNε and IFNκ) all bind to and signal via the type I IFN receptor complex. The type I receptor consists of two main IFNAR1, IFNAR2c receptor chains and other accessory proteins. The pathway above (WP585) describes the Type I Interferon signaling pathways and shows both classical IFN signaling via the JAK-STAT pathway (dark lines) and other non-canonical IFN signaling pathways. Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP585 CPTAC Assay Portal]
last edited

Authors

Sham.uk, MaintBot, Jildau, Khanspers, MartijnVanIersel, Egonw, and AlexanderPico

Cited In

Organism

Homo sapiens

Communities

CPTAC

Annotations

Pathway Ontology: Jak-Stat signaling pathway immune response pathway

Participants

Label Type Compact Identifier
GAB2 Protein ncbigene:9846
CRK GeneProduct ncbigene:1398
CBL Protein ncbigene:867
RAPGEF1 Protein ncbigene:2889
RPS6KB1 Protein ncbigene:6198
GTP Metabolite chebi:15996
PTPN6 GeneProduct ncbigene:5777
IFNAR2b Protein ncbigene:3455
JAK1 GeneProduct ncbigene:3716
MAPKAP1 Protein ncbigene:79109
CRKL Protein ncbigene:1399
EIF4E Protein ncbigene:1977
PIAS1 GeneProduct ncbigene:8554
EIF4EBP1 Protein ncbigene:1978
RPTOR Protein ncbigene:57521
PDCD4 Protein ncbigene:27250
STAT3 Protein ncbigene:6774
IRS1 Protein ncbigene:3667
SOCS1 Protein ncbigene:8651
SOCS3 Protein ncbigene:9021
FYN GeneProduct ncbigene:2534
IFNAR1 Protein ncbigene:3454
STAT1 Protein ncbigene:6772
STAT2 Protein ncbigene:6773
EIF4B Protein ncbigene:1975
PIK3CD Protein ncbigene:5293
Rac1 Protein ncbigene:5879
PTPN11 GeneProduct ncbigene:5781
MAP2K3 Protein ncbigene:5606
STAT4 Protein ncbigene:6775
Zap70 GeneProduct ncbigene:7535
GDP Metabolite chebi:17552
CrkL Protein ncbigene:1399
PTPRC GeneProduct ncbigene:5788
IRF9 Protein ncbigene:10379
PIAS3 GeneProduct ncbigene:10401
RPS6KA4 Protein ncbigene:8986
STAT4 Protein ncbigene:6775
TYK2 Protein ncbigene:7297
FRAP1 Protein ncbigene:2475
MLST8 Protein ncbigene:64223
EIF4A1 Protein ncbigene:1973
Lck GeneProduct ncbigene:3932
REL Protein ncbigene:5966
CREB1 Protein ncbigene:1385
STAT5 Protein ncbigene:6776
PRMT1 Protein ncbigene:3276
MAP2K6 Protein ncbigene:5608
STAT2 Protein ncbigene:6773
MTOR Protein ncbigene:2475
RAP1A Protein ncbigene:5906
IRS2 Protein ncbigene:8660
RPS6KA5 Protein ncbigene:9252
PIK3R1 Protein ncbigene:5295
VAV1 Protein ncbigene:7409
RPS6 Protein ncbigene:6194
MAP3K1 Protein ncbigene:4214
GNB2L1 Protein ncbigene:10399
MAPK14 Protein ncbigene:1432
IFNAR2a Protein ncbigene:3455
STAT1 Protein ncbigene:6772
STAT1 Protein ncbigene:6772
IFNAR2c Protein ncbigene:3455
STAT3 Protein ncbigene:6774
Rac1 Protein ncbigene:5879
PIK3R2 Protein ncbigene:5296
STAT1 Protein ncbigene:6772
STAT3 Protein ncbigene:6774
STAT3 Protein ncbigene:6774
STAT1 Protein ncbigene:6772
STAT2 Protein ncbigene:6773

References

  1. Novick D, Cohen B, Rubinstein M. Soluble interferon-alpha receptor molecules are present in body fluids. FEBS Lett. 1992 Dec 21;314(3):445–8. PubMed Europe PMC Scholia
  2. Uzé G, Lutfalla G, Gresser I. Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell. 1990 Jan 26;60(2):225–34. PubMed Europe PMC Scholia
  3. Uddin S, Yenush L, Sun XJ, Sweet ME, White MF, Platanias LC. Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3’-kinase. J Biol Chem. 1995 Jul 7;270(27):15938–41. PubMed Europe PMC Scholia
  4. Domanski P, Witte M, Kellum M, Rubinstein M, Hackett R, Pitha P, et al. Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling. J Biol Chem. 1995 Sep 15;270(37):21606–11. PubMed Europe PMC Scholia
  5. Novick D, Cohen B, Rubinstein M. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell. 1994 May 6;77(3):391–400. PubMed Europe PMC Scholia
  6. Müller M, Briscoe J, Laxton C, Guschin D, Ziemiecki A, Silvennoinen O, et al. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature. 1993 Nov 11;366(6451):129–35. PubMed Europe PMC Scholia
  7. Colamonici OR, Domanski P. Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21. J Biol Chem. 1993 May 25;268(15):10895–9. PubMed Europe PMC Scholia
  8. David M, Chen HE, Goelz S, Larner AC, Neel BG. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol. 1995 Dec;15(12):7050–8. PubMed Europe PMC Scholia
  9. Platanias LC, Uddin S, Yetter A, Sun XJ, White MF. The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J Biol Chem. 1996 Jan 5;271(1):278–82. PubMed Europe PMC Scholia
  10. Yan H, Krishnan K, Lim JT, Contillo LG, Krolewski JJ. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction. Mol Cell Biol. 1996 May;16(5):2074–82. PubMed Europe PMC Scholia
  11. Uddin S, Gardziola C, Dangat A, Yi T, Platanias LC. Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase. Biochem Biophys Res Commun. 1996 Aug 23;225(3):833–8. PubMed Europe PMC Scholia
  12. Uddin S, Sher DA, Alsayed Y, Pons S, Colamonici OR, Fish EN, et al. Interaction of p59fyn with interferon-activated Jak kinases. Biochem Biophys Res Commun. 1997 Jun 9;235(1):83–8. PubMed Europe PMC Scholia
  13. Owczarek CM, Hwang SY, Holland KA, Gulluyan LM, Tavaria M, Weaver B, et al. Cloning and characterization of soluble and transmembrane isoforms of a novel component of the murine type I interferon receptor, IFNAR 2. J Biol Chem. 1997 Sep 19;272(38):23865–70. PubMed Europe PMC Scholia
  14. Burfoot MS, Rogers NC, Watling D, Smith JM, Pons S, Paonessaw G, et al. Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. J Biol Chem. 1997 Sep 26;272(39):24183–90. PubMed Europe PMC Scholia
  15. Ahmad S, Alsayed YM, Druker BJ, Platanias LC. The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. J Biol Chem. 1997 Nov 28;272(48):29991–4. PubMed Europe PMC Scholia
  16. Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, et al. Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10626–31. PubMed Europe PMC Scholia
  17. Song MM, Shuai K. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J Biol Chem. 1998 Dec 25;273(52):35056–62. PubMed Europe PMC Scholia
  18. You M, Yu DH, Feng GS. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol. 1999 Mar;19(3):2416–24. PubMed Europe PMC Scholia
  19. Platanias LC, Uddin S, Bruno E, Korkmaz M, Ahmad S, Alsayed Y, et al. CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors. Exp Hematol. 1999 Aug;27(8):1315–21. PubMed Europe PMC Scholia
  20. Farrar JD, Smith JD, Murphy TL, Murphy KM. Recruitment of Stat4 to the human interferon-alpha/beta receptor requires activated Stat2. J Biol Chem. 2000 Jan 28;275(4):2693–7. PubMed Europe PMC Scholia
  21. Baychelier F, Nardeux P-C, Cajean-Feroldi C, Ermonval M, Guymarho J, Tovey MG, et al. Involvement of the Gab2 scaffolding adapter in type I interferon signalling. Cell Signal. 2007 Oct;19(10):2080–7. PubMed Europe PMC Scholia
  22. Samarajiwa SA, Mangan NE, Hardy MP, Najdovska M, Dubach D, Braniff S-J, et al. Soluble IFN receptor potentiates in vivo type I IFN signaling and exacerbates TLR4-mediated septic shock. J Immunol. 2014 May 1;192(9):4425–35. PubMed Europe PMC Scholia